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ABSTRACT
To facilitate the measurement of intramolecular
distances in solvated RNA systems, a combination
of spin-labeling, electron paramagnetic resonance
(EPR), and molecular dynamics (MD) simulation is
presented. The fairly rigid spin label 2,2,5,5-tetra-
methyl-pyrrolin-1-yloxyl-3-acetylene (TPA) was
base and site specifically introduced into RNA
through a Sonogashira palladium catalyzed cross-
coupling on column. For this purpose 5-iodo-
uridine, 5-iodo-cytidine and 2-iodo-adenosine phos-
phoramidites were synthesized and incorporated
into RNA-sequences. Application of the recently
developed ACE chemistry presented the main
advantage to limit the reduction of the nitroxide to
an amine during the oligonucleotide automated
synthesis and thus to increase substantially the
reliability of the synthesis and the yield of labeled
oligonucleotides. 4-Pulse Electron Double
Resonance (PELDOR) was then successfully used
to measure the intramolecular spin–spin distances
in six doubly labeled RNA-duplexes. Comparison of
these results with our previous work on DNA
showed that A- and B-Form can be differentiated.
Using an all-atom force field with explicit solvent,
MD simulations gave results in good agreement
with the measured distances and indicated
that the RNA A-Form was conserved despite
a local destabilization effect of the nitroxide label.
The applicability of the method to more complex
biological systems is discussed.
INTRODUCTION
RNA and its structural diversity has gained major
attention in the last 10 years, in particular through the
ﬁnding of RNAi as a natural antiviral mechanism of cells
(1,2) and of riboswitches, a class of RNAs in bacteria,
specialized in translational regulation (3). Furthermore,
the folding of RNA and its conformational changes,
induced by interactions with proteins, metal ions or small
molecules, are essential for its biological function. This, in
conjunction with a growing number of X-ray structures,
makes RNA an ever increasingly interesting target for
drug interactions and design.
In order to rationally approach RNA as a 3D target,
simple, fast and accurate methods to gain structural and
dynamical information are necessary. Electron
Paramagnetic Resonance (EPR) has already proved its
eﬃciency in characterizing the structural environment of
paramagnetic centers (4–7), as well as the global arrange-
ment of domains in proteins and protein complexes
(8–13). Yet, EPR-based studies on the local structure of,
e.g. metal ion binding sites (14,15) or of tertiary structure
elements in RNA (16) and RNA/protein complexes
(17,18) are rare. One reason for the lack of EPR studies
related to tertiary RNA structures is that they require site
directed and eﬃcient labeling of RNA domains with
nitroxides and subsequent measurements of the distance
between these nitroxides. It is only recently that strategies
were developed to spin label the phosphate backbone
(17,19), the sugar moiety (16,20) or the uridine base
(21–23) of RNA. Furthermore, pulsed EPR sequences
like pulsed electron double resonance (PELDOR) (24–26)
or double quantum coherence EPR (DQC-EPR) (27) had
to be introduced, which are capable to reliably and
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and overcome thereby the distance limit of  2nm for
continuous wave EPR techniques (29). First applications
of PELDOR (30,31) and DQC (32) to duplex RNAs have
been reported.
Despite these advances, each of the RNA spin labeling
strategies mentioned above has its disadvantages and
limitations. The major disadvantage of spin labeling
RNA bases is the restriction to uridine. Either a
5-iodouridine (21) or a 4-thiouridine (22,23) is incorpo-
rated into the RNA during the automated phos-
phoramidite synthesis and then coupled with
the acetylenic nitroxide derivative 2,2,5,5-tetramethyl-
pyrrolin-1-yloxyl-3-acetylene (TPA) or a methanethio-
sulfonate nitroxide (MTSSL), respectively.
Advantageous of the TPA labeling is the chemically
stable and geometrically fairly rigid acetylenic linker,
whereas the disulﬁde bridge formed by MTSSL is
chemically unstable and leads to the loss of the N3
imino proton, inducing structural distortions. The spin
labeling of sugar moieties is also restricted with respect
to label sites, at the moment to the 20 site of pyrimidines
(20). The largest ﬂexibility with respect to the choice of
label site is given by spin labeling a speciﬁc phosphate
group using phosphorothioates in combination with a
iodomethylnitroxide (19). However, in this case the 20 site
of the nucleotide 50 to the label side has to be protected or
replaced with a 20 deoxyribose to avoid strand cleavage
and the mixture of RP and SP diastereomers makes a
translation of the measured distance into RNA structure
more diﬃcult. With respect to PELDOR, it should be
mentioned that a parameter free and reliable extraction of
a distance from the time trace requires the observation of
a dipolar modulation. This can be achieved if most of the
sample is labeled (480%) and the distance distribution is
small. Thus, highly eﬃcient labeling strategies with rigid
labels, a broad ﬂexibility with respect to label sites and
small structural perturbations are needed.
Here, we report an extension of RNA base speciﬁc
labeling to cytosine and the purine adenine, in addition to
a considerable increase of the yield of TPA labeled RNAs
using ACetoxyEthyl orthoester (ACE) chemistry.
PELDOR measurements for each duplex-RNA yielded a
dipolar modulation, from which the distance between the
spin labels distances could be extracted. Furthermore,
molecular dynamics (MD) simulations gave results in
good agreement with the measured distances and indi-
cated that the TPA label induces only a small and local
structural distortion.
RESULTS AND DISCUSSION
As we already had learned from our DNA work (33),
the introduction of acetylenic spin labels postsynthetically
on 5-iodo-20-deoxyuridine during the oligonucleotide
solid-phase synthesis presents several advantages in
comparison to the derivatization in solution: the required
amount of spin label is smaller, the yields are better and
a simple washing step removes all excess reagents.
Furthermore, the method can be extended to various
labels, e.g. pyrene for ﬂuorescence studies (34) or
Fluorescence Resonance Energy Transfer (FRET) mea-
surements (35). In order to successfully apply this method
to RNA, we synthesized a series of iodinated RNA-
building blocks (Figure 1).
In addition to the pyrimidine bases U and C iodinated
at the 5 position, we also modiﬁed a purine base A at the
2 position, which brings more ﬂexibility in the choice of
the labeled nucleotide and therefore of the spin-label
position in the strand. This ﬂexibility is particularly
important for future EPR studies or NMR based
‘Paramagnetic Relaxation Enhancement’ measurements
on biological systems. We took also into consideration
the orientation of the nitroxide spin label in the RNA,
which can be directed for duplexes either into the major
(for U, C and potentially for A) or into the minor groove
[for A and G (36)]. Therefore, RNA–protein interactions,
for example, could be studied without any interference of
the label with the structure of the complex.
Initially, we decided to use the current standard
phosphoramidite chemistry with the acid-labile
4,40-dimethoxytrityl group (DMT) and the ﬂuoride-labile
tert-butyldimethylsilyl (TBDMS) group for protection of
the 50-OH and 20-OH, respectively (37,38). 5-Iodouridine-
phosphoramidite 1 is commercially available but can also
be easily obtained in three steps from 5-iodouridine using
standard methods. The key step for the synthesis of
5-iodocytidine was the iodination of the partially
protected cytidine with iodic acid and iodine (39,40)
(for the scheme and numbering of the compounds
see supporting information Scheme 1). Standard depro-
tection/protection steps led to the phosphoramidite.
For the minor groove modiﬁcation, the nucleoside
2-iodoadenosine was synthesized in four steps from
guanosine according to procedures described in the
literature (41–43). In particular, the iodination was
performed with iodine, copper iodide and methylene
iodide via a radical mechanism. The phosphoramidite
was obtained without diﬃculties after protection of the
exocyclic amino group with formamidine (21).
The phosphoramidites 1 and 4 were coupled success-
fully during synthesis of RNA 12 mers with the same
eﬃciency as the phosphoramidites of the natural nucleo-
bases. Key reaction for the derivatization on solid-phase
was the Sonogashira palladium(II)-catalyzed cross-cou-
pling reaction of the above iodo compounds with
TPA 6 (Figure 2).
Direct transfer of the procedure reported for DNA
failed for RNA, in part due to its lower reactivity: three
successive cross-couplings were necessary to achieve
nearly quantitative yields in the case of 5-iodo-uridine in
RNA (44), instead of two for 5-iodo-desoxyuridine in
DNA. Hereby we envisaged also a serious side reaction for
some of the RNA-building blocks, in particular for A.
Detailed analysis showed it to be the reduction of the
nitroxide to the corresponding amine. For example,
a molecular mass of 16g mol
 1 less than the calculated
one (minus oxygen) was often observed in MALDI-MS,
as well as a minor peak corresponding to a mass of  30g
mol
 1 (cleavage of NO). Puriﬁcation by anion-exchange
HPLC did not allow a complete separation of these
Nucleic Acids Research, 2007, Vol. 35, No. 9 3129side-products. When checking the RNA-synthesis cycle
routinely performed for the oligonucleotides synthesis
using TBDMS as a 20-protecting group, we observed
the same problem with the oxidation step iodine in
pyridine/water as already suggested by Gannett et al. (45).
The spin label could be ﬁrst oxidized to the nitrone by the
halogen and then react with water as proton donor to
yield the hydroxylamine. Under the acidic conditions
for the cleavage of the DMT group with dichloroacetic
acid (DCA), this hydroxylamine could be protonated,
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Figure 1. Phosphoramidites prepared for incorporation of iodinated bases into protected RNA oligomers.
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Figure 2. Sonogashira cross-coupling during the solid-phase synthesis (example of 2-iodoadenosine).
3130 Nucleic Acids Research, 2007, Vol. 35, No. 9the leaving water could give itself the necessary hydride for
the formation of the amine (46).
As we recently have had excellent results with the newly
developed ACE chemistry (47–49), we changed our
protocol to this procedure. This chemistry does not use
iodine for the oxidation but water-free t-butyl hydroper-
oxide instead. In addition, the 50-deprotection in each
step is accomplished by ﬂuoride, which is a much milder
reagent than the acid DCA (46). The acid is responsible
for further degradation of the oxidized nitroxide label.
Thus the combination of the mild oxidation agent t-butyl
hydroperoxide with the neutral ﬂuoride is advantageous
for the survival of the nitroxide spin label during
RNA synthesis. The ACE protected 5-iodouridine-
phosphoramidite 2 was purchased from Dharmacon,
Chicago, IL, USA, whereas 2-iodoadenosine-
phosphoramidite 5 and 5-iodocytidine-phosphoramidite
3 were synthesized in ﬁve steps from the protected
nucleoside as previously described (50). The synthesis of
5 is shown in Scheme 1.
The 50 and 30 hydroxyl groups were simultaneously
protected with the Markiewicz silyl group (51) in a 72%
yield for 2-iodoadenosine and 71% for 5-iodocytidine.
Selective introduction of the ACE-group at the 20-OH
was then performed with tris(2-acetoxyethyl)orthoformate
under acidic catalysis (pyridinium-para-toluenesulfonate,
ppTs). Once the reaction started, 4-tert-butyldimethyl-
siloxy-3-penten-2-one was added to increase the speed
of the reaction by shifting the equilibrium towards
the product. The completion of the reaction is
achieved within 36–48h after addition of the
ketone, which led to very good yields of about 90%
for both nucleobases. After quantitative deprotection
of the Markiewicz group with a freshly prepared
tetramethylethylenediamine (TEMED), HF solution in
acetonitrile, the 50-hydroxyl group was protected at 08C
with benzhydryloxy-bis(trimethylsilyloxy)chlorosilane
under basic conditions (67% for 2-iodoadenosine and
79% for 5-iodocytidine). A pure phosphoramidite was
formed by reaction of the 30-hydroxyl group with methyl-
N,N,N0,N-tetraisopropylphosphor-diamidite, activated
with tetrazole.
Phosphoramidites 3 and 5 were incorporated into RNA
sequences (Table 1) on a 0.2 mol scale, and labeled with
the nitroxide TPA by the same method and the same
amount of reagents as in case of the TBDMS-chemistry
(1 mol synthesis). In this case, only two successive
Sonogashira cross-couplings with the spin label were
necessary to obtain quantitative yields. Analysis of the
identity and purity of the synthesized oligonucleotides
were performed with MALDI-Tof mass spectrometry,
analytical HPLC and enzymatic digestion (see supporting
information).
To stress the advantage of using the ACE chemistry,
we compared the results obtained by both methods
for RNA 4, modiﬁed with a spin-labeled adenosine.
Using the TBDMS chemistry, a signiﬁcant amount of
reduced oligonucleotide was observed, as shown on the
HPLC-chromatogram in Figure 3, and a second puriﬁca-
tion was necessary to obtain a pure enough sample for
the EPR measurement, but which therefore lowered the
yield. The ACE chemistry enabled us to achieve much
better yields, as the proportion of reduced RNA was
signiﬁcantly decreased already after the ﬁrst HPLC run
yielding comparable MS-spectra (Figure 3). According
to experiments in solution, this side reaction is due
to the treatment of the oligonucleotides with disodium-
2-carbamoyl-2-cyanoethylene-1,1-dithiolate-trihydrate to
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oligonucleotide synthesis. For all the labeled RNAs,
reproducible results could be obtained with the ACE
chemistry. Yields were 7–10 OD for a 12-mer (35–50%) to
be compared with 4–10 OD with the TBDMS chemistry
on a ﬁve times larger scale (4–10%).
To determine if the spin label disturbs the RNA
structure, UV-melting and Circular Dichroism (CD)
studies were performed. The UV-melting curves showed
a destabilization of the duplexes between 1.5 and 5.18C,
slightly higher than for spin labeled DNA-duplexes (33),
which probably results from the geometry of the A-helix,
with a very deep but narrow major groove and a very wide
but shallow minor groove. CD spectroscopy conﬁrmed
that the A-helix is conserved with a similar ellipticity
for both modiﬁed and unmodiﬁed RNAs. Both data
together indicate that TPA does not signiﬁcantly perturb
the A-form RNA structure (for detailed data see
supporting information).
We then subjected RNA-duplexes 1–6 to 4-pulse-
ELDOR measurements (Figure 4a). The PELDOR pulse
sequence recovers the magnetic dipole coupling !dd
between two electron spins A and B from which the
spin–spin distance rAB can be calculated according to the
equation given in Figure 4b. The principle of the pulse
sequence is the following: The detection sequence is
applied at a microwave frequency  A which is in resonance
with the A spin and creates an refocused echo.
The amplitude of this echo is monitored as function of
the time position t of an inversion pulse applied at a
microwave frequency  B, which is in resonance with the B
spin. This stimulated ﬂip of the B spin induces a sudden
change in the Larmor frequency of the spin A by  !dd,s o
that the A spins precess with this altered frequency in the
transversal plane, leading to a non-perfect refocusing of
the A spins. By variation of the time position t of the
inversion pulse, the dephasing angle can be changed which
induces a periodic modulation of the A-spin echo intensity
Table 1. Spin-labeled RNA and their corresponding masses; the chemistry used for the preparation is indicated by a cross, a: RNA6 is
non-self-complementary
RNA Sequence Method Calc. mass (g mol
 1) Meas. mass (g mol
 1)
TBDMS ACE
13 0 CGA CUA UAG UCG   3958.6 3963.4
50 GCU GAU AUC AGC
23 0 CUG ACU AGU CAG   3958.6 3962.1
50 GAC UGA UCA GUC
33 0 GCU GAC UAU AGU CAG C 50   5244.3 5248.4
50 CGA CUG AUA UCA GUCG3 0
43 0 CGA CAU AUG UCG 50    3958.6 3960.0
50 GCU GUA UAC AGC 30
53 0 GCA CAU ACG UAU GUG C 50   5244.3 5244.5
50 CGU GUA UGC AUA CAC G 30
6
a 30 CGA GUG AUA CAU CGC 50   4938.1 4938.5
50 GCU CAC UAU GUA GCG 30 4915.1 4920.6
  0 1 02 03 04 05 0
3963.0
3947.4
3959.7
3944.2
4000 4000
3948.3
4000
3927.0
(a) (b)
t/min
Figure 3. (a) HPLC-chromatogram of RNA 4 synthesized with the TBDMS chemistry and the corresponding MS spectra of the separated fractions
as indicated with an arrow. The reduced oligonucleotide strand shows a mass of 3947–3948g mol
 1 and the spin labeled strand of 3963g mol
 1.
(b) HPLC-chromatogram and MS spectrum of RNA 4, synthesized with the ACE chemistry without second HPLC puriﬁcation. The calculated
mass of the spin labeled RNA 4 is 3958.6g mol
 1.
3132 Nucleic Acids Research, 2007, Vol. 35, No. 9by the dipolar coupling !dd. The observation of this
dipolar modulation is crucial for a reliable and parameter
free distance calculation.
Figure 4 shows as an example the measured PELDOR
time traces and the corresponding distances obtained by
Tikhonov regularization (52–54) for RNA 3 and RNA 4.
Both RNAs show clearly visible oscillations in the time
traces and one dominant peak in the Tikhonov regular-
izations at 38.7 and 21.9A ˚ for RNA 3 and 4, respectively.
The peaks of weak intensity at larger distances are most
likely due to a slight orientation selection, which is
compensated by the Tikhonov regularization by adding
more distances. An additional explanation may be
coaxially end-to-end stacking of the helices (see support-
ing information) (30).
Also all other RNAs exhibit visible oscillations
(supporting information) and the extracted mean dis-
tances are listed in Table 2. The observation of the dipolar
modulation for each RNA proves that the labeling
eﬃciency is high and that the label is suﬃciently rigid to
yield small distance distributions. Compared to earlier
PELDOR studies on RNA (30,31), the dipolar oscillations
are deeper for the spin-label TPA used here, which might
be attributed to its increased rigidity. Accordingly, the
modulation depth is comparable with TPA-labeled duplex
DNAs (33). A recent PELDOR study on duplex DNAs
labeled at the phosphate backbone also shows oscillations
of comparable depth (55).
To be able to translate the measured N–O/N–O
distances into RNA structures, we performed 50ns
all-atom MD simulations of all doubly labeled RNAs
in explicit water solvent. The simulations yielded
single-peaked distance distributions (measured between
the oxygen atoms), whose mean and width are reported
in Table 2. Mean distances from the PELDOR measure-
ments compare well with the ones from the MD
simulations started from generic A-form RNA duplexes.
A linear ﬁt through all data points yields
r(MD)¼0.93 r(PELDOR)þ1.0A ˚ with a standard
deviation of 1.9A ˚ and a correlation coeﬃcient of 0.976
(Figure 5). This correlation indicates that the RNA and
DNA duplexes retain their conformations in frozen
aqueous buﬀer solution if 20% ethylene glycol is added.
Furthermore, the PELDOR experiments allow us to
distinguish between A- and B-form helices, as long as
the peak width is smaller than the distance diﬀerence
between both conformations. Thus, RNA/DNA 1 and 3
can clearly be assigned to A- and B-conformations,
whereas the distance diﬀerence is below this limit for
RNA/DNA 2.
Apart from the distances, MD simulations may provide
detailed information on the structure and conformational
dynamics of these RNA systems (56–62). Here, we are
interested in to what extent the label disturbs the RNA
structure and dynamics. As a representative example,
Figure 6a shows the time evolution of the root mean
squared deviations (RMSD) of the MD trajectory
obtained for RNA 1. The black line displays the RMSD
from the standard A-form, while the red line reﬂects the
RMSD from the standard B-form of RNA 1. During the
50ns simulation, the RMSD from the A-form (2.7A ˚ in
average) is always smaller than the RMSD from the
B-form (3.7A ˚ in average). Note that there are no
transitions between the A and B-form. The time evolu-
tions of the RMSDs pertaining to the two RNA forms are
correlated, indicating that the structure simultaneously
moves away from both the A and the B-form that is,
it approaches a non-standard structure of RNA. Besides
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Figure 4. (a) 4-Pulse ELDOR sequence. (b) Relation between the dipolar coupling !dd and the spin–spin distance rAB.  0 is the vacuum permeability,
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A-form or B-form by RMSD values, the classiﬁcation of
a dinucleotide step as A-form or B-form based on the
positioning of phosphorus atoms with respect to the
middle frame was performed using the program
X3DNA (63). All dinucleotide steps maintain A-form
quite well ( 80%), except for step 6 (i.e. between base
pairs U6:A19 and A7:U18), which is only to 20% in
A-form (Figure 6).
To study to what extent the spin labels aﬀect the overall
structure of RNA 1, the green line in Figure 6a shows the
RMSD from the A-form obtained for unlabeled RNA 1.
As may be expected, the latter is smaller (1.6A ˚ in average)
than in the case of the spin-labeled RNA 1 (2.7A ˚ in
average). The RMSD from the B-form of unlabeled RNA
1 (data not shown) looks quite similar with an average of
3.9A ˚ . Moreover, the time evolution of the RMSD of
unlabeled RNA 1 misses the characteristic modulations
seen in the RMSD of labeled RNA 1, e.g. at times t¼10
and 30ns. A closer analysis reveals that the latter are
caused by occasional openings of hydrogen bonds between
canonical Watson–Crick pairs, in particular in the vicinity
of the labeled bases uracil 8 and uracil 20 of RNA 1.
To illustrate this eﬀect for the two base pairs between the
two labeled bases, Figure 6b shows the distance between
the H3 atom of uracil 6 and the N1 atom of adenine 19
and Figure 6c shows the distance between the N1 atom of
adenine 7 and the H3 atom of uracil 18 (for the numbering
of the bases see Table 2). When a hydrogen bond is
formed the distance remains around 2.0A ˚ , while the
distance may increase up to 7–8A ˚ , when the hydrogen
bond is broken. It is interesting to note that the
spin labels hardly perturb the two labeled bases uracil
Table 2. RNA sequences and the corresponding N–O/N–O distances from PELDOR and Molecular Dynamics (MD) simulations
RNA Sequence R(PELDOR) [A ˚ ] r(MD) [A ˚ ]
13 0CGA CU
20A
19 UAG UCG 19.3 1.2 [DNA 23.3 0.6] 18.0 (2.4) [DNA 21.4 (1.6)]
50GCU GAU
6 AU
8C AGC
23 0CUG ACU AGU CAG 33.7 3.9 [DNA 34.7 1.4] 30.5 (2.4) [DNA 33.0 (2.7)]
50GAC UGA UCA GUC
33 0GCUGACUAUAGUCAGC 38.7 1.3 [DNA 44.8 5.0] 36.2 (3.1) [DNA 43.3 (2.5)]
50CGACUGAUAUCAGUCG
43 0CGACAUAUGUCG 21.9 0.8 24.7 (0.8)
50GCUGUAUACAGC
53 0GCACAUACGUAUGUGC 33.6 2.6 34.3 (1.8)
50CGUGUAUGCAUACACG
63 0GCAGUGAUACAUCGC 26.9 1.3 24.6 (2.4)
50GCUCACUAUGUAGCG
The PELDOR distances are given along with the experimental error determined from the full width of the peak at half height. The MD distances
are given including the width of the distance distribution in brackets. For RNA 1–3, the mean distances for the sequence analog B-form DNA (33)
is given in square brackets. The superscript numbers in the sequence of RNA 1 are used in the discussion of the MD part to identify the bases.
15 20 25 30 35 40 45 50
15
20
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40
45
50
r
(
M
D
)
/
Å
r(PELDOR)/Å
Figure 5. Correlation of the PELDOR and MD distances for RNAs
1–6 (squares) and DNAs 1–3 (open circles).
Figure 6. Molecular dynamics simulation results obtained for RNA 1.
(a) Time evolution of the RMSD from the standard A-form (black line)
and B-form (red line) for labeled RNA 1. For comparison, the RMSD
from the A-form obtained for unlabeled RNA 1 is also shown (green
line). (b) and (c): Hydrogen bonding as monitored by (b) the distance
between the H3 atom of uracil 6 and the N1 atom of adenine 19 and
(c) the distance between the N1 atom of adenine 7 and the H3 atom of
uracil 18. While the hydrogen bonds of labeled RNA 1 (black lines)
open occasionally, the hydrogen bonds of unlabeled RNA 1 (red lines)
remain stable.
3134 Nucleic Acids Research, 2007, Vol. 35, No. 98 and uracil 20, but mainly aﬀect the structure of
dinucleotide step 6 including the base pairs U6:A19 and
A7:U18. For comparison, Figure 6 also shows (red lines)
the corresponding results obtained for unlabeled RNA 1,
which shows no indication of hydrogen bond opening.
The opening of the Watson–Crick hydrogen bonds may be
a reason for the observed lower melting temperatures
found for the spin-labeled RNAs.
In conclusion, the spin-label TPA was introduced into
RNA by Sonogashira cross-coupling on column during
oligonucleotide solid phase synthesis utilizing the bases A,
U and C.
Application of the recently developed ACE chemistry
presented the main advantage to limit the reduction of
the nitroxide TPA into the corresponding amine during
the oligonucleotide synthesis and thereby to increase
substantially the reliability of the synthesis and the yield
of labeled oligonucleotides. Thus, we are able now to
introduce the spin label either into the major or minor
groove of duplex RNA and to adenine, uridine and
cytosine. The combination of site speciﬁc labeling with the
advantage of the rigid label renders this method advanta-
geous for distance measurements.
PELDOR experiments enabled us to measure the
intramolecular distances in the six doubly labeled
RNA-duplexes with signiﬁcant modulations depth of up
to 40% and allowed us to distinguish A-form RNA from
B-form DNA duplexes. MD simulations on the same
oligonucleotides gave results in good agreement with the
measured distances and showed that the destabilization
eﬀect of the label is only local. Thus the combination of
this spin-label strategy with PELDOR and MD opens
a way to study structures in complex RNA folds and how
they change upon binding of metals, small organic ligands
or proteins.
EXPERIMENTAL PART
Chemical synthesis
The reactions were monitored by thin-layer chromato-
graphy (TLC) analysis on silica gel aluminum plates (silica
gel 60 F254, 0.2mm, Merck, Columbus, OH, USA).
Column chromatography was performed on silica gel
(40–63 m, 230–400 mesh, Merck). Technical solvents
were used after distillation for chromatography; absolute
solvents, dried over molecular sieve, were purchased from
FLUKA.
1H,
13C and
31P NMR spectra were recorded
with a Bruker AMX250/DPX 250at 250MHz or
AMX400at 400MHz as indicated. Electron Spray
Ionization (ESI) masses were collected on a VG
Platform II (Fisons Instruments, San Carlos, CA, USA).
Elemental analyses were performed on CHN-O-Rapid
from Foss-Heraeus, Hanau, Germany.
5-Iodo-uridine-phosphoramidites 1 and 2. Commercially
available from Glen Research, Sterling, VA, USA and
Dharmacon, respectively.
2-Iodo-adenosine-phosphoramidites 4 and 5. All reactions
were carried out under a protective argon atmosphere.
20,30,50-Tri-O-acetyl-guanosine 7. A mixture of 35g
(0.12mol) guanosine, 70ml (0.74mol, 6.2 eq) acetic
anhydride in 140ml of dried dimethylformamide/pyridine
5/2 was heated at 758C for 4h. The resulting solution was
cooled to 48C, at which the product crystallized overnight.
After ﬁltration, washing with isopropanol and drying
overnight, 46g (91%) 20,30,50-tri-O-acetyl-guanosine were
obtained.
Rf (CH2Cl2/MeOH: 9/1): 0.64;
1H NMR (250MHz,
DMSO-d6): d[ppm] 10.80 (brs, 1H, NH), 7.95 (s, 1H, H8),
6.57 (s, 2H, NH2), 6.01 (d, J¼6Hz, 1H, H10), 5.81 (dt,
J¼6.0Hz, 1H, H20), 5.52 (dd, J¼5.8Hz, 1H, H30), 4.42–
4.24 (m, 3H, H40 and H50), 2.12 (s, 3H, OAc), 2.06 (s, 3H,
OAc), 2.05 (s, 3H, OAc);
13C NMR (62.9MHz, DMSO-
d6): d[ppm] 170.1–169.4–169.2 (3C¼O), 156.7 (C6), 153.7
(C2), 151.1 (C4), 136.7 (C8), 116.8 (C5), 84.4 (C10), 79.5
(C40), 72.0 (C20), 70.3 (C30), 63.1 (C50), 20.5–20.3–20.1
(3CH3); ESI-MS (þ): calc. 409.1, found 410.0 [MH]
þ.
20,30,50-Tri-O-acetyl-10-deoxy-10-(2-amino-6-chloropurine)-
b-D-ribofuranose 8. To a solution of pre-dried 20,30,50-tri-
O-acetyl-guanosine (30g, 73mmol) in 150ml abs acetoni-
trile were added at room temperature, in this order, 24.3g
(0.14mol, 2 eq) tetraethylammoniumchloride, pre-dried
overnight at 808C over P2O5, 9.3ml N,N-dimethylaniline
(73mmol, 1 eq) and 41ml freshly distilled phosphoryl
chloride (0.43mol, 6 eq). After stirring for 10min under
reﬂux (the oil bath was preheated to 1008C), volatile
materials were evaporated immediately in vacuo. The
resulting oily yellow foam was dissolved in 300ml
chloroform and 200ml cold water and stirred for 15min
under ice-cooling. The layers were separated and the
aqueous phase was extracted with 3 100ml chloroform.
The combined organic phases were washed with 6 50ml
of cold water and 6 100ml of a 5% NaHCO3 aqueous
solution. After drying over Na2SO4, 150ml isopropanol
was added to the organic phase, which was then slowly
evaporated to 100ml. The product crystallized at 48C, was
ﬁltered, washed with isopropanol and dried overnight
in vacuo. The crude product could directly be used for the
next step without any further puriﬁcation. Yield: 19g
(61%). Rf (CH2Cl2/MeOH: 95/5): 0.52;
1H NMR
(250MHz, CDCl3): d[ppm] 7.84 (s, 1H, H8), 5.95 (d,
J¼4.8Hz, 1H, H10), 5.89 (dt, J¼5.1Hz, 1H, H20), 5.67
(dd, J¼4.9Hz, 1H, H30), 4.41–4.25 (m, 3H, H40 and H50),
2.07 (s, 3H, OAc), 2.03 (s, 3H, OAc), 2.01 (s, 3H, OAc);
13C NMR (62.9MHz, CDCl3): d[ppm] 170.5–169.7–169.4
(3C¼O), 159.2 (C6), 153.1 (C2), 151.8 (C4), 140.7 (C8),
126.7 (C5), 86.6 (C10), 79.9 (C40), 72.7 (C20), 70.5 (C30),
64.0 (C50), 20.7–20.5–20.4 (3CH3); ESI-MS (þ): calc.
427.1, found 428.0 [MH]
þ.
20,30,50-Tri-O-acetyl-10-deoxy-10-(6-chloro-2-iodopurine)-b-
D-ribofuranose 9. Iodine (11.3g, 44mmol), diiodo-
methane (36ml, 10 eq), copper iodide (9.3g, 49mmol)
and isopentyl nitrite (17.8ml, 0.13mol) were added to
a solution of 19.0g of 20,30,50-tri-O-acetyl-10-deoxy-10-
(2-amino-6-chloropurine)-b-D-ribofuranose (44mmol)
in 200ml abs THF. The suspension was stirred at reﬂux
for 45min. After cooling at RT, the mixture was ﬁltered
oﬀ and the solution evaporated. Followed a puriﬁcation
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99/1). Yield: 19.4g (82%). Rf (CH2Cl2/MeOH: 98/2): 0.28;
1H NMR (250MHz, CDCl3): d[ppm] 8.16 (s, 1H, H8),
6.25 (m, 1H, H10), 5.73 (m, 1H, H20), 5.53 (m, 1H, H30),
4.39 (m, 1H, H40), 4.34 (m, 1H, H50), 2.11 (s, 3H, OAc),
2.08 (s, 3H, OAc), 2.04 (s, 3H, OAc);
13C NMR
(62.9MHz, CDCl3): d[ppm] 170.4–169.9–169.6 (3C¼O),
152.0 (C6), 150.9 (C4), 143.2 (C2), 132.2 (C8), 117.0 (C5),
84.7 (C10), 80.8 (C40), 73.3 (C20), 70.6 (C30), 62.9 (C50),
20.8–20.6–20.4 (3CH3); ESI-MS (þ): calc. 538.0, found
538.9 [MH]
þ.
2-Iodo-adenosine 10. To 750ml of abs ethanol saturated
with ammonia at 08C was added 20,30,50-tri-O-acetyl-10-
deoxy-10-(6-chloro-2-iodopurine)-b-D-ribofuranose
(7.16g, 13.3mmol). The solution was stirred 1h at 08C
and 24h at RT. The solvent was then removed under
reduced pressure and the residue treated with a NaOCH3
solution (25mM) for 1h at RT to remove the last acetyl
group. After neutralization with DOWEX 50W-8, ﬁltra-
tion of the resin and evaporation of the solvent, the crude
product was puriﬁed by crystallization in water. Yield:
4.45g (85%). Rf (CH2Cl2/MeOH: 9/1): 0.24;
1H NMR
(400MHz, DMSO-d6): d[ppm] 8.29 (s, 1H, H8), 7.73
(brs, 2H, NH2), 5.80 (d, 1H, H10, J¼6.2Hz), 5.46
(d, J¼6.2Hz, 1H, 20-OH), 5.20 (d, J¼3.7Hz, 1H,
30-OH), 5.04 (t, J¼6.3Hz, 1H, 50-OH), 4.52
(dd, J¼6.2Hz and 11.2Hz, 1H, H20), 4.11 (m, 1H, H30),
3.93 (m, 1H, H40), 3.67–3.51 (m, 2H, H50);
13C NMR
(100.6MHz, DMSO-d6): d[ppm] 155.9 (C6), 149.7 (C4),
136.4 (C8), 121.3 (C2), 120.8 (C5), 87.2 (C10), 85.8 (C40),
73.6 (C20), 70.7 (C30), 61.4 (C50); ESI-MS ( ): calc. 393.1,
found 391.9 [M-H]
 .
N,N-Dimethyl-N0-formamidine-2-iodo-adenosine 11. A
mixture of 2-iodo-adenosine (4.44g, 11.3mmol), 7.5ml
N,N-dimethylformamide-dimethylacetal (56.5mmol, 5 eq)
in 90ml abs dimethylformamide (DMF) was heated at
508C for 1h. After evaporation of the solvent, the
obtained oil was puriﬁed through a ﬂash chromatography
(CH2Cl2/MeOH: 95/5). Yield 3.5g (69%). Rf (CH2Cl2/
MeOH: 9/1): 0.36;
1H NMR (250MHz, DMSO-d6):
d[ppm] 8.83 (s, 1H, CH), 8.42 (s, 1H, H8), 5.87–5.50–
5.23 (3s, 3H, 3OH), 5.03 (d, 1H, H10, J¼5.25Hz), 4.57
(m, 1H, H20), 4.47–4.09 (m, 1H, H30), 3.96 (m, 1H, H40),
3.72–3.35 (m, 2H, H50), 3.25 (s, 3H, CH3), 3.24 (s, 3H,
CH3);
13C NMR (62.9MHz, DMSO-d6): d[ppm] 159.3
(CH), 158.4 (C6), 151.9 (C4), 141.0 (C2), 125.6 (C8), 120.3
(C5), 87.2 (C10), 86.8 (C40), 73.5 (C20), 70.4 (C30), 61.4
(C50), 34.6 (2CH3); ESI-MS (þ): calc. 448.0, found 448.8
[MH]
þ; Anal. calc. for C13H17IN6O4: C 34.84%, H 3.82%,
N 18.75%; found: C 34.60%, H 4.10%, N 18.50%.
30,50-Tetraisopropyldisiloxane-N,N-dimethyl-N0-formami-
dine-2-iodo-adenosine 12. N,N0-dimethyl-N-formamidine-
2-iodo-adenosine (600mg, 1.33mmol) was dissolved in
5ml abs pyridine and cooled at 08C. 1,3-Dichloro-1,1,3,3-
tetraisopropyldisiloxane (0.46ml, 1.1 eq) was added
dropwise for 1h. After further stirring for 30min at 08C,
the reaction was quenched with 0.2ml water, the solution
concentrated in vacuo and coevaporated with toluene.
The residue was dissolved in 30ml CH2Cl2 and washed
with 5% aqueous NaHCO3. After separation of the two
layers, the aqueous phase was extracted once with 15ml
CH2Cl2. The combined organic phases were washed with
20ml saturated aqueous NaCl. The separated aqueous
phase was extracted with 15ml CH2Cl2. The organic
phases were combined, dried with Na2SO4, ﬁltered and
evaporated. A ﬂash chromatography (EtOAc/n-hex: 8/2 to
10/0) aﬀorded 660mg product (72%). Rf (CH2Cl2/MeOH:
98/2): 0.33;
1H NMR (250MHz, DMSO-d6): d[ppm] 8.80
(s, 1H, CH), 8.25 (s, 1H, H8), 5.86 (1d, 1H, OH), 5.62
(d, 1H, H10), 4.66–4.56 (m, 2H, H20 and H30), 4.01–3.97
(m, 3H, H40and H50), 3.23 (s, 3H, CH3), 3.14 (s, 3H, CH3),
1.15–0.90 (m, 28H, Si-iPr);
13C NMR (62.9MHz, DMSO-
d6): d[ppm] 159.4 (CH), 158.2 (C6), 152.7 (C4), 141.1 (C2),
125.8 (C8), 120.3 (C5), 89.4 (C10), 80.8 (C40), 73.3 (C20),
70.8 (C30), 61.1 (C50), 40.9 and 34.8 (2CH3), 17.3–16.9
(CH(CH3)2), 13.9–12.4 (CH(CH3)2); ESI-MS (þ): calc.
690.19, found 691.2 [MH]
þ; Anal. calc. for
C25H43IN6O5Si2: C 43.47%, H 6.27%, N 12.17%;
found: C 43.44%, H 6.33%, N 12.03%.
20-O-bis-(Acetoxyethyloxy)methylester-30,50-tetraisopropyl-
disiloxane-N,N-dimethyl-N0-formamidine-2-iodo-adenosine
13. A solution of 12 (970mg, 1.4mmol), tris(2-acetox-
yethyl)orthoformate (1.04g, 2.3 eq), 3ml abs dichloro-
methane and pyridinium p-toluenesulfonate (70mg, 0.2
eq) was stirred at RT. As soon as the reaction has
progressed well ( 6h after TLC analysis), 4-tert-butyldi-
methylsiloxy-3-penten-2-one (0.6ml, 1.8 eq) was added,
the solution stirred for 40h at RT and ﬁnally neutralized
with 105 l TEMED (0.5 eq). Followed a direct ﬂash
chromatography (EtOAc/n-hex/MeOH/TEMED: 50/50/
1/0.5) to yield a yellow foam (1.11g, 87%). Rf (CH2Cl2/
MeOH: 95/5): 0.42;
1H NMR (250MHz, CDCl3): d[ppm]
8.80 (s, 1H, CH), 8.00 (s, 1H, H8), 6.04 (m, 1H, H10), 5.65
(s, 1H, CH(ACE)), 4.61–4.55 (m, 1H, H20), 4.43–4.41 (m,
1H, H30), 4.30–4.08 (m, 6H, CH2(ACE), H40and H50),
3.99–3.80 (m, 5H, H50 and CH2(ACE)), 3.18 (s, 3H, CH3),
3.15 (s, 3H, CH3), 1.99 and 1.93 (2s, 6H, OAc), 1.92–1.05
(m, 28H, Si-iPr);
13C NMR (62.9MHz, CDCl3): d[ppm]
170.9 (C¼O), 159.7 (CH), 158.5 (C6), 151.1 (C4), 139.4
(C2), 126.7 (C8), 120.0 (C5), 112.3 (CH(ACE)), 88.6 (C10),
81.4 (C40), 76.5 (C20), 69.1 (C30), 63.6, 63.3, 63.2, 61.0
(CH2(ACE)), 59.9 (C50), 41.6 and 36.5 (2CH3
formamidine), 20.9 (CH3(ACE)), 17.6–16.9 (CH(CH3)2),
13.3–12.7 (CH(CH3)2); MALDI-MS (þ): calc. 908.3,
found 909.3 [MH]
þ and 931.2 [MNa]
þ.
20-O-bis-(Acetoxyethyloxy)methylester-N,N-dimethyl-N0-
formamidine-2-iodo-adenosine 14. TEMED/HF was
freshly and separately prepared: 0.89ml TEMED
(5.9mmol) was dissolved in 2ml acetonitrile at 08C and
0.15ml hydroﬂuoric acid (48% in water, 4.1mmol) was
added slowly in 2min. This mixture was stirred for 5min
at 08C and added dropwise in 5min at RT to a solution of
1.08g 20-O-ACE-30,50-O-TIPS-N,N-dimethyl-N0-formami-
dine-2-iodo-adenosine 13 in 2ml acetonitrile. After 2h
stirring, the solution was concentrated in vacuo, the oily
residue was dissolved in 5ml CH2Cl2,1 m ln-hexane and
0.1ml TEMED and puriﬁed through a ﬂash
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Yield: 711mg (90%). Rf (EtOAc/MeOH: 95/5): 0.13;
1H
NMR (250MHz, CDCl3): d[ppm] 8.81 (s, 1H, CH), 7.78
(s, 1H, H8), 5.84 (d, J¼7.8Hz, 1H, H10), 5.17 (s, 1H,
CH(ACE)), 4.96 (m, 1H, H20), 4.45 (m, 1H, H30), 4.29
(m, 1H, H40), 4.06–3.92 (m, 5H, CH2(ACE) and H50),
3.72–3.45 (m, 5H, H50 and CH2(ACE)), 3.21 (s, 3H, CH3),
3.20 (s, 3H, CH3 formamidine), 1.99 and 1.93 (2s, 6H,
OAc);
13C NMR (62.9MHz, CDCl3): d[ppm] 170.8 and
170.8 (C¼O), 160.2 (CH), 158.7 (C6), 150.9 (C4), 141.6
(C2), 127.6 (C8), 119.1 (C5), 112.7 (CH(ACE)), 89.1 (C10),
87.7 (C40), 76.6 (C20), 71.9 (C30), 63.4 (CH2(ACE)), 63.3
(C50), 62.8 and 62.6 (CH2(ACE)), 41.7 and 35.6 (CH3
formamidine), 20.9 (CH3(ACE)); ESI-MS ( ): calc. 666.1,
found: 700.9 [MCl]
 .
20-O-bis-(Acetoxyethyloxy)methylester-50-O-bis(trimethyl-
silyloxy)benzhydryloxysilyl-N,N-dimethyl-N0-formamidine-
2-iodo-adenosine 15. Compound 14 (660mg, 0.99mmol)
and diisopropylamine (169 l, 1 eq) were dissolved in 5ml
abs dichloromethane and cooled to 08C. Simultaneously,
210 l diisopropylamine were added dropwise in 1min
to a solution of benzhydryloxy-bis(trimethylsilyloxy)
chlorsilane (BzHCl, 630mg, 1.5 eq) in 2ml abs CH2Cl2.
After 5min stirring at RT, this last solution was added
dropwise and in portions to the previous one: ﬁrst 0.5 eq
BzHCl in 15min, then twice 0.2 eq in 10min and ﬁnally
portions of 0.1 eq until the completion of the reaction
(TLC analysis). The mixture was washed with 10ml 8%
aqueous NaHCO3 and 10ml brine. The layers were
separated and the organic phase dried with Na2SO4 and
evaporated. The crude product was puriﬁed through
a ﬂash chromatography (EtOAc/n-hex/acetone/Et3N:
35/45/20/0.5), which aﬀorded 700mg (67%) of 15. Rf
(CH2Cl2/MeOH: 95/5): 0.36;
1H NMR (250MHz,
CDCl3): d[ppm] 8.92 (s, 1H, CH), 8.04 (s, 1H, H8),
7.31–7.12 (m, 10H, phenyl), 6.09 (d, 1H, H10, J¼4.5Hz),
5.88 (s, 1H, CH-Ph), 5.33 (s, 1H, CH(ACE)), 4.58 (m, 1H,
H20), 4.21–4.00 (m, 6H, H30,H 4 0 and CH2(ACE)),
3.88–3.82 (m, 1H, H50), 3.76–3.64 (m, 5H, H50 and
CH2(ACE)), 3.21 (s, 3H, CH3 formamidine), 3.15 (s, 3H,
CH3 formamidine), 1.97 (s, 6H, OAc),  0.02 to 0.01
(2s, 18H, SiMe3);
13C NMR (62.9MHz, CDCl3): d[ppm]
169.3 (C¼O), 158.4 (CH), 157.7 (C6), 150.2 (C4), 142.5
(CAr), 138.3 (C2), 126.7 (C8), 126.7, 124.9, 124.9, 124.7
(Ph-H), 118.5 (C5), 111.3 (CH(ACE)), 85.5 (C10), 83.0
(C40), 76.7 (CH-Ph), 75.4 (C20), 68.8 (C30), 61.6
(CH2(ACE)), 61.6 (C50), 61.4 and 60.8 (CH2(ACE)),
40.01 and 33.8 (CH3 formamidine), 19.4 and 19.3
(CH3(ACE)), 0.00 (SiMe3); ESI-MS (þ): calc. 1054.3,
found: 1055.3 [MH]
þ; Anal. calc. for C41H59IN6O13Si3:
C 46.67%, H 5.64%, N 7.97%; found: C 46.63%,
H 5.88%, N 7.32%.
20-O-bis-(Acetoxyethyloxy)methylester-30-O-
(N,N-diisopropylamino)methoxyphosphinyl-50-O-
bis-(trimethylsilyloxy)benzhydryloxysilyl-N,N-dimethyl-
N0-formamidine-2-iodo-adenosine 5. About 216 l Methyl-
N,N,N0,N0-tetraisopropylphosphordiamidite (0.75mol)
and 666 l of a 0.45M tetrazole solution in acetonitrile
(0.5 eq) were solved in 2ml abs dichloromethane.
After 5min at RT, this solution was added dropwise
to a solution of 20-O-ACE-50-O-BzH-N,N-dimethyl-
N0-formamidine-2-iodo-adenosine (632mg, 0.60mmol) in
2ml abs dichloromethane, cooled at 08C. After 5min at
08C and 11h at RT, the reaction mixture was quenched
with 175 l ethanol (5 eq) and evaporated. A puriﬁcation
with a ﬂash chromatography (n-hex/acetone/Et3N: 70/30/
0.5) yielded 546mg of the phosphoramidite (75%).
Rf (n-hex/acetone: 70/30): 0.20 and 0.11;
1H NMR
(250MHz, CDCl3): d[ppm] 9.00 (s, 2H, CH), 8.11 and
8.08 (2s, 2H, H8), 7.25–7.37 (2m, 20, Phenyl), 6.20 (s, 2H,
CH–Ph), 5.95–5.96 (m, 2H, 2H10), 5.40 and 5.48 (2s, 2H,
CH(ACE)), 4.72 (m, 2H, H20), 4.50 (m, 2H, 2H30),
4.12–4.18 (m, 10H, 2H40 and 2CH2(ACE)), 3.61–3.81
(m, 14H, 2H50, 2H500, 2CH2(ACE) and 4CH(iPr)),
3.34–3.43 (m, 6H, OCH3), 3.26 (s, 6H, CH3 formamidine),
3.18 (s, 6H, CH3 formamidine), 2.00–2.06 (4s, 12H,
CH3(ACE)), 1.16–1.22 (m, 24H, iPr), 0.04–0.11 (s, 36H,
SiMe3);
31P NMR (162MHz, CDCl3): d[ppm] 150.82 and
150.71 (1/1); ESI-MS (þ): calc. 1215.4, found 1215.8.
50-O-(4,40-Dimethoxytriphenylmethyl)-N,N-dimethyl-N0-
formamidine-2-iodo adenosine 16. About 1.50g N,N-
dimethyl-N0-formamidine-2-iodo-adenosine (3.34mmol)
were dissolved in 35ml abs DMF. A solution of
4,40-dimethoxytriphenylmethylchloride (1.39g, 1.2 eq) in
7ml abs pyridine was added dropwise in three portions.
After 3h at RT, the reaction was quenched with 5ml
methanol, the solution evaporated in vacuo and coevapo-
rated with toluene. The obtained foam was taken up in
dichloromethane and washed with a saturated NaHCO3
aqueous solution. The two layers were separated and the
organic phase extracted with CH2Cl2. The combined
organic phases were dried with Na2SO4, ﬁltered and
evaporated. A ﬂash chromatography yielded 1.69g of the
puriﬁed product (67%). Rf (CH2Cl2/MeOH: 95/5): 0.39;
1H NMR (250MHz, CDCl3): d[ppm] 8.87 (s, 1H, CH),
7.87 (s, 1H, H8), 7.26–7.07 (m, 9H, DMT), 6.70–6.66 (m,
4H, DMT), 5.87 (d, J¼6.0Hz, 1H, H10), 4.71
(dd, J¼5.8Hz, 1H, H20), 4.34–4.31 (m, 2H, H30 and
H40), 3.70 and 3.69 (2s, 6H, OCH3), 3.39–3.22 (m, 2H,
H50), 3.19 (s, 3H, CH3), 3.18 (s, 3H, CH3);
13C NMR
(62.9MHz, CDCl3): d[ppm] 159.0 (C6), 158.5 (CH), 151.2
(C4), 144.5 (C2), 140.0 (C8), 135.6 (DMT), 130.0–125.6
(DMT), 119.6 (C5), 113.1 (DMT), 91.8 (C10), 85.3 (C40),
74.7 (C20), 72.4 (C30), 63.8 (C50), 55.2 (OMe), 35.5 and
41.1 (2CH3); ESI-MS (þ): calc. 750.2, found 751.2 [MH]
þ;
Anal. calc. for C34H35IN6O6: C 54.41%, H 4.70%,
N 11.20%; found: C 54.00%, H 4.84%, N 10.92%.
50-O-(4,40-Dimethoxytriphenylmethyl)-20-
O-(tert-butyldimethylsilyl)-N,N-dimethyl-N0-formami-
dine-2-iodo-adenosine 17. To a solution of 1.82g of
50-O-(4,40-dimethoxytriphenylmethyl)-N,N-dimethyl-N0-
formamidine-2-iodo-adenosine in 40ml of a mixture
tetrahydrofurane (THF)/pyridine: 1/1 were added
under argon, silver nitrate (536mg, 1.3 eq) and
t-butyltrimethylsilylchloride (1M in THF, 3.4ml, 1.4
eq). The suspension was stirred 7h at RT in the dark.
After ﬁltration over Celite, washing with CH2Cl2, the
clear solution was evaporated. The residue was dissolved
Nucleic Acids Research, 2007, Vol. 35, No. 9 3137in CH2Cl2, the organic phase washed with a saturated
NaHCO3 aqueous solution. The aqueous phase was then
extracted twice with dichloromethane. The combined
organic phases were ﬁnally dried with Na2SO4, ﬁltered,
concentrated in vacuo and coevaporated with toluene.
A ﬂash chromatography (EtOAc/n-hex: 7/3 then 100/0)
enabled to separate the two isomers. The 20-O-isomer was
obtained in a 61% yield, the unwanted 30-O-isomer in a
10% yield. Rf (CH2Cl2/MeOH: 95/5): 0.39;
1H NMR
(250MHz, CDCl3): d[ppm] 8.90 (s, 1H, CH), 8.01 (s, 1H,
H8), 7.47–7.16 (m, 9H, DMT), 6.86–6.80 (m, 4H, DMT),
6.03 (d, J¼5.0Hz, 1H, H10), 4.85 (dd, J¼4.9Hz, 1H,
H20), 4.32–4.22 (m, 2H, H30 and H40), 3.79 (s, 6H, OCH3),
3.55–3.41 (m, 2H, H50), 3.27 (s, 3H, CH3), 3.23 (s, 3H,
CH3), 0.88 (s, 9H, tBu), 0.05 and  0.05 (2s, 6H, SiCH3);
13C NMR (62.9MHz, CDCl3): d[ppm] 159.1 (C6), 158.4
(CH), 151.8 (C4), 144.5 (C2), 136.7 (C8), 135.6–135.5
(DMT), 130.0–126.3 (DMT), 119.9 (C5), 113.1–113.2
(DMT), 88.2 (C10), 84.1 (C40), 75.9 (C20), 71.5 (C30),
63.4 (C50), 55.1 (OMe), 35.4 and 41.4 (2CH3), 25.6 and
25.5 (SitBu),  5.3 and  4.9 (SiMe); ESI-MS (þ): calc.
864.8, found 865.4 [MH]
þ; Anal. calc. for C40H49IN6O6Si:
C 55.55%, H 5.71%, N 9.72%; found: C 55.46%,
H 5.92%, N 9.49%.
30-O-(2-Cyanethoxydiisopropylphosphine)-50-O-(4,40-
dimethoxytriphenylmethyl)-20-O-(tert butyldimethylsilyl)-
N,N-dimethyl-N0-formamidine-2-iodo-adenosine 4. A solu-
tion of 705mg 17 (0.83mmol) and 420 l diisopropylethy-
lamine (3 eq) in 20ml abs dichloromethane was cooled
to 08C. About 280 l 2-cyanoethyldiisopropylchlorophos-
phoramidite (1.5 eq) were then added under argon.
The mixture was stirred for 5min at 08C then 2h at RT
and ﬁnally diluted with 20ml CH2Cl2. The organic phase
was washed twice with a saturated NaHCO3 solution,
dried with Na2SO4, ﬁltered and concentrated in vacuo.
The crude product was puriﬁed through a ﬂash chroma-
tography (EtOAc/n-hex: 8/2). Yield: 745mg (86%).
Rf (EtOAc/n-hex: 80/20): 0.43 and 0.38;
1H NMR
(250MHz, CDCl3): d[ppm] 9.03 (s, 2H, CH), 8.16 and
8.14 (2s, 2H, H8), 7.61–7.37 (m, 18H, DMT), 6.98–6.93
(m, 8H, DMT), 6.14 (m, 2H, H10), 5.09 (m, 2H, H20),
4.49–4.46 (m, 4H, H30 and H40), 3.93 (s, 6H, OCH3), 3.92
(s, 6H, OCH3), 3.76–3.72 (m, 8H, OCH2 and H50), 3.40 (s,
3H, CH3), 3.36 (s, 3H, CH3), 2.82, 2.48 (m, 4H, CH2CN),
1.31–1.21 (m, 24H, iPr), 1.18 and 1.02 (2s, 18H, SitBu),
0.16–0.04 (m, 12H, SiMe2);
31P NMR (162MHz, CDCl3):
d[ppm] 151.13 and 149.78; ESI-MS(þ): calc. 1064.4,
found: 1065.1 [MH]
þ.
5-Iodo-cytidine-phosphoramidite 3.
20,30,50-Tri-O-acetyl-cytidine, hydrochloride 18.
Acetylchloride (17.5ml, 0.24mol) was added to a solution
of 10g cytidine (40mmol) in 65ml acetic acid. After
stirring overnight at RT, the solution was concentrated
and the obtained white powder recrystallized in ethanol.
Yield: 13g (78%). Rf (CH2Cl2/MeOH: 9/1): 0.64;
1H NMR (250MHz, DMSO-d6): d[ppm] 10.19 (brs, 1H,
NH), 9.00 (brs, 1H, NH), 8.04 (d, J¼7.8Hz, 1H, H6),
6.30 (d, J¼5.8Hz 1H, H5), 5.92 (d, J¼4.3Hz, 1H, H10),
5.50 (dd, J¼4.5 and 5.8Hz, 1H, H20), 5.34 (m, 1H, H30),
4.29 (m, 3H, H40-H50), 2.07 (s, 9H, OAc);
13C NMR
(62.9MHz, DMSO-d6): d[ppm] 170.0 and 169.3 (3C¼O),
159.3 (C4), 146.9 (C2), 145.0 (C6), 94.8 (C5), 89.1 (C10),
79.3 (C40), 72.4 (C20), 69.3 (C30), 62.7 (C50),
20.5–20.3–20.2 (3CH3); ESI-MS (þ): calc. 405.1, found
370.1 [MCl]
 .
20,30,50-Tri-O-acetyl-5-iodo-cytidine (19). Iodine (4.11g,
14.4mmol) was added to a suspension of 20,30,50-tri-O-
acetyl-cytidine, hydrochloride (10.0g, 24mmol) in 90ml
CH3COOH/CCl4: 1/1. After heating to 408C, iodic acid
(5.2g, 0.9 eq) was added and the mixture stirred at 408C
for 48h. The suspension was concentrated in vacuo and
the residue taken up in 200ml dichloromethane. The
organic phase was washed with 100ml 5% aqueous
NaHCO3, dried with Na2SO4 and evaporated. A ﬂash
chromatography (CH2Cl2/MeOH: 98/2 to 90/10) yielded
10.09g of 19 (69%). Rf (CH2Cl2/MeOH: 95/5): 0.45;
1H NMR (250MHz, DMSO-d6): d[ppm] 8.09 (s, 1H, H6),
8.05 (s, 1H, NH), 6.83 (s, 1H, NH), 5.82 (d, J¼4.3Hz,
1H, H10), 5.45 (dd, J¼4.5 and 6.3Hz, 1H, H20), 5.38
(m, 1H, H30), 4.34 (m, 3H, H40), 4.22 (m, 2H, H50), 2.07
(s, 9H, OAc);
13C NMR (62.9MHz, DMSO-d6): d[ppm]
170.0 and 169.3 (3C¼O), 164.9 (C4), 163.9 (C2), 148.6
(C6), 89.8 (C10), 78.9 (C40), 72.4 (C20), 69.7 (C30), 63.0
(C50), 57.7 (C5), 20.6 and 20.3 (3CH3); ESI-MS (þ): calc.
495.0, found 495.9 [MH]
þ.
5-Iodo-cytidine 20. About 7.61g 20,30,50-tri-
O-acetyl-5-iodo-cytidine (15.4mmol) were dissolved in
20ml of a sodium methanolate solution (0.1M in
methanol) and stirred for 1h at RT. The mixture was
neutralized with DOWEX 50W-X8 (H
þ), ﬁltered and
evaporated in vacuo. Pure 5-iodo-cytidine could be
obtained without any further puriﬁcation in a 86%
yield (4.84g). Rf (CH2Cl2/MeOH: 8/2): 0.36;
1H NMR
(250MHz, DMSO-d6): d[ppm] 8.43 (s, 1H, H6), 7.81 (s,
2H, NH2), 5.74 (m, 1H, H10), 3.96 (m, 2H, H20and H30),
3.85 (m, 1H, H40), 3.69 (m, 2H, H50);
13C NMR
(62.9MHz, DMSO-d6): d[ppm] 163.7 (C4), 154.1 (C2),
147.6 (C6), 89.4 (C10), 84.0 (C40), 74.3 (C20), 68.7 (C30),
59.8 (C50), 56.7 (C5); ESI-MS ( ): calc. 369.0, found
368.1 [M-H]
 .
N,N-dimethyl-N0-formamidine-5-iodo-cytidine
21. 5-Iodo-cytidine 20 (4.07g, 11.5mmol) was dissolved
under argon in 30ml abs dimethylformamide.
N,N-dimethylformamide-dimethylacetal (8.1ml, 5 eq)
was added and the solution heated at 508C. After
completion of the reaction ( 2h), the mixture was
concentrated and puriﬁed through a ﬂash chromatogra-
phy (CH2Cl2/MeOH: 9/1). Yield: 4.44g (95%).Rf
(CH2Cl2/MeOH: 9/1): 0.33;
1H NMR (250MHz,
DMSO-d6): d[ppm] 8.61 (s, 1H, CH), 8.58 (s, 1H, H6),
5.73 (d, 1H, H10), 5.45–5.26–5.01 (3 brs, 3H, 3OH), 3.98
(m, 2H, H20and H30), 3.89 (m, 1H, H40), 3.67 (m, 2H,
H50), 3.21 (s, 3H, CH3), 3.14 (s, 3H, CH3);
13C NMR
(62.9MHz, DMSO-d6): d[ppm] 163.9 (C4), 158.3 (CH),
154.4 (C2), 147.7 (C6), 89.8 (C10), 84.0 (C40), 74.4 (C20),
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calc. 424.0, found 425.0 [MH]
þ.
30,50-O-Tetraisopropyldisiloxane-N,N-dimethyl-N0-forma-
midine-5-iodo-cytidine 22. N,N-dimethyl-N0-formamidine-
5-iodo-cytidine (1.0g, 2.4mmol) was dissolved in 10ml
abs pyridine and cooled at 08C. 1,3-Dichloro-1,1,3,3-
tetraisopropyldisiloxane (810 l, 1.1 eq) was added drop-
wise in 10min. After further stirring for 30min at RT,
the reaction was quenched with 0.2ml water, the solution
concentrated in vacuo and coevaporated with toluene.
The residue was dissolved in 30ml CH2Cl2 and washed
with 30ml 5% aqueous NaHCO3. After separation of
the two layers, the aqueous phase was extracted once with
15ml CH2Cl2. The combined organic phases were washed
with 15ml saturated aqueous NaCl. The separated
aqueous phase was extracted with 10ml CH2Cl2.
The organic phases were combined, dried with Na2SO4,
ﬁltered and evaporated. A ﬂash chromatography
(CH2Cl2/MeOH: 97/3) followed to yield 1.11g product
(71%). Rf (CH2Cl2/MeOH: 95/5): 0.30;
1H NMR
(250MHz, CDCl3): d[ppm] 8.76 (s, 1H, CH), 8.14
(s, 1H, H6), 5.74 (m, 1H, H10), 4.42–4.36 (m, 1H, H20),
4.29–4.23 (m, 2H, H30 and H40), 4.20–3.98 (m, 2H, H50),
3.24 (s, 3H, CH3 formamidine), 3.21 (s, 3H, CH3
formamidine), 1.12–1.02 (m, 28H, iPr);
13C NMR
(62.9MHz, CDCl3): d[ppm] 169.0 (C4), 160.0 (CH),
156.3 (C2), 146.8 (C6), 92.2 (C10), 82.1 (C40), 75.2 (C20),
69.14 (C30), 69.09 (C50), 60.4 (C5), 41.4 and 35.5 (CH3
formamidine), 17.7–16.9 (CH(CH3)2), 13.4–12.6
(CH(CH3)2); ESI-MS (þ): calc. 666.2, found 667.1
[MH]
þ; Anal. calc. for C24H43IN4O6Si2: C 43.24%,
H 6.50%, N 8.40%; found: C 43.41%, H 6.70%,
N 8.26%.
20-O-bis-(Acetoxyethoxy)methylester-30,50-O-tetraisopro-
pyldisiloxane-N,N-dimethyl-N0-formamidine-5-iodo-cyti-
dine 23. A solution of 22 (967mg, 1.45mmol),
tris(2-acetoxyethyl)orthoformate (1.08g, 2.3 eq), 4ml abs
dichloromethane and pyridinium p-toluenesulfonate
(73mg, 0.2 eq) was stirred at RT. As soon as the
reaction has progressed well (overnight after TLC
analysis), 4-tert-butyldimethylsiloxy-3-penten-2-one
(0.6ml, 1.8 eq) was added, the solution stirred for 48h
at RT and ﬁnally neutralized with 105 l TEMED (0.5
eq). Followed a direct ﬂash chromatography (EtOAc/n-
hex/MeOH/TEMED: 50/49/1/0.5 to yield 23 (1.12g,
87%). Rf (CH2Cl2/MeOH: 95/5): 0.30;
1H NMR
(250MHz, CDCl3): d[ppm] 8.67 (s, 1H, CH), 8.16 (s,
1H, H6), 5.81 (m, 1H, H10), 5.74 (s, 1H, CH(ACE)),
4.20–4.12 (m, 8H, CH2(ACE)), 4.04–3.77 (m, 5H, H20/
H30/H40/H50), 3.16 (s, 3H, CH3 formamidine), 3.15 (s, 3H,
CH3 formamidine), 1.99 (s, 6H, CH3(ACE)), 1.04–0.91
(m, 28H, iPr);
13C NMR (62.9MHz, CDCl3): d[ppm]
171.0 and 171.0 (C¼O), 169.1 (C4), 158.9 (CH), 155.2
(C2), 146.1 (C6), 112.1 (CH ACE), 90.2 (C10), 81.8 (C40),
76.6 (C20), 69.1 (C30), 67.7 (C50), 63.8–63.4–62.2–60.9
(CH2 ACE), 59.2 (C5), 41.4 and 35.5 (CH3 formamidine),
21.0 and 20.9 (CH3(ACE)), 17.8–16.9 (CH(CH3)2),
13.5–12.7 (CH(CH3)2); ESI-MS (þ): calc. 884.3, found
885.2 [MH]
þ; Anal. calc. for C33H57IN4O12Si2: C 44.79%,
H 6.49%, N 6.33%; found: C 44.96%, H 6.54%,
N 6.28%.
20-O-bis-(Acetoxyethyloxy)methylester-N,N-dimethyl-N0-
formamidine-5-iodo-cytidine 24. TEMED, HF was freshly
and separately prepared: 0.85ml tetramethylethylendia-
mine (5.7mmol) was dissolved in 2ml acetonitrile at 08C
and 0.14ml hydroﬂuoric acid (48% in water, 4.1mmol,
3.5 eq) was added slowly in 2min. This mixture was stirred
for 5min at 08C and added dropwise in 5min at RT to a
solution of 1.0g 20-O-ACE-30,50-O-TIPS-N,N-dimethyl-
N0-formamidine-5-iodo-cytidine in 4ml acetonitrile. After
2h stirring, the solution was concentrated in vacuo, the
oily residue was dissolved in 10ml CH2Cl2, 2ml hexane
and 0.2ml TEMED and puriﬁed through a ﬂash
chromatography (93/7/0.5: EtOAc/MeOH/TEMED).
Yield: 726mg (quantitative); Rf (CH2Cl2/MeOH: 95/5):
0.16;
1H NMR (250MHz, CDCl3): d[ppm] 8.65 (s, 1H,
CH), 8.10 (s, 1H, H6), 5.56 (d, 1H, H10), 5.46 (s, 1H,
CH(ACE)), 4.74 (m, 1H, H20), 4.31 (m, 1H, H30),
4.17–4.11 (m, 4H, CH2(ACE)), 4.10 (m, 1H, H40),
3.97–3.91 (m, 1H, H50), 3.78–3.70 (m, 5H, H50 and
CH2(ACE)), 3.16 (2s, 6H, CH3 formamidine), 2.00
(s, 6H, CH3(ACE));
13C NMR (62.9MHz, CDCl3):
d[ppm] 170.9 (C¼O), 169.1 (C4), 159.8 (CH), 156.0 (C2),
149.4 (C6), 113.0 (CH ACE), 93.3 (C10), 85.7 (C40), 76.2
(C20), 69.5 (C30), 63.3–63.1–63.0–62.8 (CH2(ACE)), 62.7
(C50), 41.7 and 35.6 (CH3 formamidine), 21.0 and 20.9
(CH3(ACE)); ESI-MS (þ): calc. 642.10, found 643.0
[MH]
þ; Anal. calc. for C21H31IN4O11: C 39.26%, H
4.86%, N 8.72%; found: C 39.48%, H 5.09%, N 8.52%.
20-O-bis-(Acetoxyethyloxy)methylester-50-O-bis-(trimethyl-
silyloxy)benzhydryloxysilyl-N,N-dimethyl-N0-formamidine-
5-iodo-cytidine 25. 24 (635mg, 0.97mmol) and diisopro-
pylamine (136 l, 1 eq) were dissolved in 5ml abs
dichloromethane and cooled to 08C. Simultaneously,
204 l diisopropylamine were added dropwise in 1min
to a solution of benzhydryloxy-bis(trimethylsilyloxy)-
chlorsilane (BzHCl, 617mg, 1.5 eq) in 2ml abs CH2Cl2.
After 5min stirring at RT, this last solution was added
dropwise and in portions to the previous one: ﬁrst 0.5 eq
BzHCl in 15min, then twice 0.2 eq in 10min and ﬁnally
portions of 0.1 eq until the completion of the reaction
(TLC analysis). The mixture was washed with 20ml 8%
aqueous NaHCO3 and 20ml brine. The layers were
separated and the organic phase dried with Na2SO4 and
evaporated. The crude product was puriﬁed through a
ﬂash chromatography (EtOAc/n-hex/acetone/Et3N: 50/
30/20/0.5 then 60/20/20/0.5), which yielded 797mg (79%)
of 21. Rf (CH2Cl2/MeOH: 95/5): 0.28;
1H NMR
(250MHz, CDCl3): d[ppm] 8.65 (s, 1H, CH); 8.10 (s,
1H, H6); 7.05–7.33 (m, 10H, Phenyl); 5.92 (s, 1H, CH–
Ph); 5.77 (m, 1H, H10); 5.58 (s, 1H, CH(ACE)); 4.18–4.10
(m, 3H, H20,H 3 0,H 4 0 and H50); 4.06–4.03 (m, 1H, H50);
3.70–3.86 (m, 8H, CH2(ACE)); 3.13 (s, 3H, CH3
formamidine); 3.07 (s, 3H, CH3 formamidine); 1.95 (2s,
6H, CH3(ACE)); 0.03 (s, 18H, SiMe3);
13C NMR
(62.9MHz, CDCl3): d[ppm] 169.2 (C¼O), 167.3 (C4),
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126.5, 126.5, 125.5, 125.4, 124.9 and 124.7 (CHAr), 111.6
(CH (ACE)), 88.0 (C10), 82.2 (C40), 76.9 (CHAr), 75.2
(C20), 67.6 (C30), 66.1 (C50), 61.5, 61.5, 61.4 and 61.4
(CH2(ACE)), 59.7 (C5), 39.7 and 33.8 (CH3 formamidine),
19.2 (CH3(ACE)), 0.0 (SiMe3); ESI-MS (þ): calc. 1030.2,
found 1031.2 [MH]
þ and 1053.3 [MNa]
þ; Anal. calc. for
C41H61IN6O14Si3: C 46.59%, H 5.77%, N 5.43%; found C
46.34%, H 5.94%, N 5.43%.
20-O-bis-(Acetoxyethyloxy)methylester-30-O-(N,N-diiso-
propylamino)methoxyphosphinyl-50-O-bis-(trimethylsilylox-
y)benzhydryloxysilyl-N,N-dimethyl-N0-formamidine-5-
iodo-cytidine 3. About 0.8ml of a 0.45M tetrazole
solution in acetonitrile was added to a solution of
methyl-N,N,N0,N0-tetraisopropylphosphordiamidite
(260 l, 1.25 eq) in 2ml abs dichloromethane and stirred
5min at RT. This activated phosphorylating agent was
added dropwise to a solution of 20-O-ACE-50-O-BzH-
N,N-dimethyl-N0-formamidine-5-iodo-cytidine (741mg,
0.72mmol) in 2ml abs dichloromethane, previously
cooled to 08C. After 5min at 08C and 10h at RT, the
reaction was quenched with 330 l ethanol (5 eq) and the
solution evaporated. A ﬂash chromatography (n-hexane/
acetone/Et3N: 55/45/0.5) led to a pure phosphoramidite.
Yield 608mg (76%). Rf (n-hexane/acetone: 55/45): 0.31;
1H NMR (250MHz, CDCl3): d[ppm] 8.74 (s, 2H, CH),
8.20 and 8.19 (2s, 2H, H6), 7.25–7.40 (2m, 20, phenyl),
6.07 (s, 2H, CH-Ph), 6.00–6.02 (m, 2H, 2H10), 5.75 and
5.69 (2s, 2H, CH(ACE)), 4.31–4.32 (m, 2H, H20), 4.16–
4.27 (m, 12H, 2H30, 2H40 and 2CH2(ACE)), 3.80–3.94 (m,
12H, 2H50 and 2CH2(ACE)), 3.57–3.61 (m, 2H, iPr),
3.31–3.38 (m, 6H, OCH3), 3.26 (s, 6H, CH3 formamidine),
3.18 (s, 6H, CH3 formamidine), 2.06–2.07 (4s, 12H,
CH3(ACE)), 1.15–1.20 (m, 24H, iPr), 0.04–0.12 (s, 36H,
SiMe3);
31P NMR (162MHz, CDCl3): d[ppm] 150.81 and
150.60; ESI-MS (þ): calc. 1191.3, found 1192.4 [MH]
þ.
Oligonucleotide synthesis
The oligonucleotides were synthesized on a 1 mol scale
on a EXPEDITE synthesizer from Perseptive Biosystems,
Foster City, CA, USA, with phosphoramidites purchased
from Biospring, Frankfurt am Main, Germany (TBDMS
chemistry) or on a 0.2 mol scale on a rebuilt ABI 392
synthesizer (Applied Biosystems, Foster City, CA, USA)
with phosphoramidites purchased from Dharmacon (ACE
chemistry). Every RNA synthesis was stopped after
incorporation of the iodinated phosphoramidite without
deprotecting the 50-hydroxyl group (DMTon). The
column was removed from the synthesizer and maintained
under argon atmosphere. In the mean time 9.5mg
copper(I) iodide were dissolved in dried and deoxygenated
CH2Cl2/Et3N (1.75/0.75ml). About 150 l of this solution
were added under argon to a mixture of Pd
II(PPh3)2Cl2
(2.1mg) and TPA (2mg). The orange solution was given
into the column and moved in it back and forth using two
syringes. After a reaction time of 2.5h the column was
washed with 10ml abs CH2Cl2, dried for 10min under
vacuum and ﬂushed with argon. The Sonogashira cross-
coupling was performed twice or three times depending on
the labeled base and on the chosen chemistry for the
oligonucleotide synthesis. Note that the amounts of
reagents were not reduced for the 0.2 mol synthesis.
Then the column was reinstalled on the synthesizer to end
the synthesis of the oligonucleotide.
When using the TBDMS chemistry, the oligonucleo-
tides were cleaved from the controlled pore glass (CPG)
and the amino groups deprotected with a mixture of
ammonia (32%)/MeOH (3/1) over 24h. The TBDMS
groups were cleaved with triethylamine, HF over 24h.
After precipitation in abs. ethanol ( 208C over night), the
RNA strands were puriﬁed via anion-exchange chromato-
graphy (Dionex NucleoPac
TM PA 100 column,
250 9mm, ﬂow 5ml min
 1) on a JASCO-HPLC.
When using the ACE chemistry, the methyl group on
the phosphate was ﬁrst cleaved on-column with a 0.4M
solution of disodium-2-carbamoyl-2-cyanoethylene-
1,1-dithiolate-trihydrate (S2Na2) in DMF/H2O: 98/2 in
30min. Then, the oligonucleotides were cleaved from the
solid support and deprotected with methylamine (40% in
water): 10min at 558C for the unmodiﬁed RNA-strands
and 12h at RT for the spin labeled ones. Followed a
puriﬁcation through anion-exchange HPLC.
The oligonucleotides were desalted with PD-10
Sephadex columns from Amersham Biosciences,
Piscataway, NJ, USA and ﬁnally characterized with a
MALDI-Tof VOYAGER DE-PRO mass spectrometer
from Applied Biosystems. In case of the ACE chemistry
the ﬁnal deprotection of the 20-ACE groups was
performed under sterile conditions with a TEMED-
acetic acid buﬀer pH 3.8, 30min at 608C for all the
RNA strands.
Analysis
Calf intestine alkaline phosphatase (Sigma-Aldrich,
St. Louis, MO, USA) and Penicillium citrinum nuclease
P1 (Roche, Nutley, NJ, USA) were used for the enzymatic
digestion of ODNs (see (33) for the procedure and
supplementary data for HPLC diagram). UV-melting
curves (Tm) of the duplexes, dissolved in phosphate
buﬀer (10mM Na2HPO4, 10mM NaH2PO4, 140mM
NaCl, 2.5 M duplex, pH 7), were recorded on a Cary
UV-vis spectrophotometer equipped with a Peltier ther-
mostat from Varian. The UV absorption was measured at
a wavelength of 260nm, while the temperature was
increased with a heating rate of 0.58C min
 1. CD spectra
were measured at a temperature of 20C between 350 and
200nm on a JASCO J-710 spectropolarimeter with a
Peltier thermostat. The duplexes were dissolved in the
same buﬀer and at the same concentration as for the Tm
measurements.
PELDOR
All EPR samples had a volume of 100 l and contained
0.1mM duplex in phosphate buﬀer (140mM NaCl,
10mM Na2HPO4, 10mM NaH2PO4, 20% ethylene
glycol, pH 7). The solutions were transferred into sterile
standard quartz EPR tubes and shock frozen in liquid
nitrogen. The 4-Pulse ELDOR experiments were per-
formed on an ELEXSYS E580 pulsed X-band EPR
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dielectric ring resonator all from Bruker, Fa ¨ llanden,
Switzerland. The temperature was adjusted with a
temperature control system (ITC) in combination with a
helium cryostat both from Oxford. For the PELDOR
measurements a second microwave source was coupled
into the microwave bridge using a commercially available
set-up from Bruker. The pumping pulse was applied at the
resonance frequency  0¼ B of the resonator and the
detection pulses at a frequency  A, 80MHz higher than  B.
The resonator used exhibits in overcoupled conditions a
resonance frequency  0 of 9.7GHz, a quality factor Q of
about 100, a conversion factor k of 4 T/W and a
bandwidth of 97MHz. Accordingly, even with a frequency
oﬀset of 80MHz between  A¼ 0 and  B both pulses are
still within the bandwidth of the resonator. The pulse
lengths used for the detection pulses were 32ns and for the
pumping pulse 12ns. The amplitude of the detection
pulses was chosen to optimize the refocused echo (global
power 1kW, attenuation in the þx-channel 8.0 ( /2-
pulse), attenuation in the  x-channel 8.1 ( -pulses)). The
amplitude of the inversion pulse with frequency  B was
adjusted to a  -pulse using the pulse sequence  ( B-second
source)-T- /2( B-main source)- - ( B-main source) as far
as possible, which is usually at about 8dB of the second
source. B0 was set to a ﬁeld value so that the detection
pulses excited the low ﬁeld site of the nitroxide ﬁeld sweep
spectrum, whereas the inversion pulse selected the central
mI¼0 transition of gzz together with the mI¼0, 1
transitions of gxx and gyy. The spectra were recorded at
40K with an experiment repetition time of 14ms, a video
ampliﬁer bandwidth of 25MHz, a video ampliﬁer gain of
63dB and a 2-step phase-cycle. Usually 800 scans and 10
shots per point were accumulated. The inversion pulse was
stepped in increments of 20ns leading to a total of 166
points.
Tikhonov regularizations of the acquired time traces
were performed with the program ‘DEER 2006’ from G.
Jeschke available at http://www.mpip-mainz.mpg.de/
 jeschke/distance.html). An exponential background
ﬁtted to the last 2/3 of the time trace was subtracted
prior to the regularization. The regularization parameter
was for all regularizations between 1 and 10.
Molecular dynamics simulations
All MD simulations were performed with the GROMACS
(64) program package. The AMBER98 force ﬁeld (65) was
employed, which was implemented by us in GROMACS.
To specify the potential-energy function for the TPA spin-
label, density functional theory calculations at the
B3LYP/6-31þG(d) level were performed, using
Gaussian program (66). All non-standard force-ﬁeld
parameters of TPA (in particular, partial charges, bond
lengths and bond angles) were then derived employing the
AMBER strategy of force-ﬁeld development (67). Force-
ﬁeld parameters will be provided upon request, see (68) for
a similar study. In each simulation, the RNA was solvated
in a rectangular box of TIP3P water, keeping a minimum
distance of 10A ˚ between the solute and each face of the
box. To neutralize the system, sodium counterions were
added and water molecules were removed if they over-
lapped with the sodium ions. The largest simulation
(RNA 5) contained 32 823 atoms in a box of the
dimension 72 66 69A ˚ 3. The equation of motion was
integrated by using a leapfrog algorithm with a time step
of 2 fs. Covalent bond lengths involving hydrogen atoms
were constrained by the SHAKE algorithm with a relative
geometric tolerance of 0.0001. A cut oﬀ of 10A ˚ was used
for the non-bonding van der Waals interactions, and the
non-bonded interaction pair-list was updated every 10 fs.
Periodic boundary conditions were applied, and the
particle mesh Ewald method was used to treat electrostatic
interactions. The solute and solvent were separately
weakly coupled to external temperature baths at 300K
with a temperature-coupling constant of 0.5 ps (0.01
during the ﬁrst 100 ps). The total system was also weakly
coupled to an external pressure bath at 1atm using a
coupling constant of 5 ps. All systems were minimized and
equilibrated with the same protocol, using the program
MDRUN in double precision. Assuming that the RNAs
are initially in ideal A-form, the whole system was ﬁrst
minimized for 1000 steps. A 100 ps MD run of the water
molecules and counter ions with ﬁxed solute was then
performed, followed by a 100 ps MD run without position
constrains of the solute. The simulation was then
continued for 50ns, where the coordinates were saved
every picosecond for analysis. One nanosecond of
simulation time required about 12h using four CPUs on
a dual-core Opteron Linux cluster. The relatively long
simulation time is necessary to account for the opening
and closing of base-pair hydrogen bonds, which occurs on
a 10ns time scale (see Figure 6).
SUPPLEMENTARY DATA
Details about the oligonucleotide analyses (enzymatic
digestion, Tm-values, CD) and PELDOR spectra for RNA
1-6. This material is available free of charge via the
Internet at NAR online.
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